Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obesity in Adolescents. Reply.
Hannon TS, Arslanian SA. Hannon TS, et al. Among authors: arslanian sa. N Engl J Med. 2023 Oct 5;389(14):1344. doi: 10.1056/NEJMc2309715. N Engl J Med. 2023. PMID: 37792626 No abstract available.
Estimating insulin sensitivity and β-cell function from the oral glucose tolerance test: validation of a new insulin sensitivity and secretion (ISS) model.
Ha J, Chung ST, Springer M, Kim JY, Chen P, Chhabra A, Cree MG, Diniz Behn C, Sumner AE, Arslanian SA, Sherman AS. Ha J, et al. Among authors: arslanian sa. Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E454-E471. doi: 10.1152/ajpendo.00189.2023. Epub 2023 Dec 6. Am J Physiol Endocrinol Metab. 2024. PMID: 38054972
Obesity in Adolescents.
Hannon TS, Arslanian SA. Hannon TS, et al. Among authors: arslanian sa. N Engl J Med. 2023 Jul 20;389(3):251-261. doi: 10.1056/NEJMcp2102062. N Engl J Med. 2023. PMID: 37467499 Review. No abstract available.
Weight loss and β-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial.
Utzschneider KM, Ehrmann DA, Arslanian SA, Barengolts E, Buchanan TA, Caprio S, Edelstein SL, Hannon TS, Kahn SE, Kozedub A, Mather KJ, Nadeau KJ, Sam S, Tripputi M, Xiang AH, El Ghormli L; RISE Consortium. Utzschneider KM, et al. Among authors: arslanian sa. Obesity (Silver Spring). 2022 Aug;30(8):1579-1588. doi: 10.1002/oby.23475. Obesity (Silver Spring). 2022. PMID: 35894078 Free PMC article. Clinical Trial.
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.
Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Pérez M, Bismuth E, Dib S, Cho JI, Cox D; AWARD-PEDS Investigators. Arslanian SA, et al. N Engl J Med. 2022 Aug 4;387(5):433-443. doi: 10.1056/NEJMoa2204601. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658022 Clinical Trial.
Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE Study.
Kahn SE, Edelstein SL, Arslanian SA, Barengolts E, Caprio S, Ehrmann DA, Hannon TS, Marcovina S, Mather KJ, Nadeau KJ, Utzschneider KM, Xiang AH, Buchanan TA; RISE Consortium; Rise Consortium Investigators:. Kahn SE, et al. Among authors: arslanian sa. Diabetes Care. 2021 Sep;44(9):1948-1960. doi: 10.2337/dc21-0461. Epub 2021 Jun 16. Diabetes Care. 2021. PMID: 34135015 Free PMC article. Clinical Trial.
123 results